This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

NATHAN J. SALTZ, M.D.

AMA Arch Surg. 1960;81(4):618-623.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The replacement of circulating blood volume has been, for a long time, the accepted therapy for shock due to loss of intravascular fluid. This concept is solidly based on principles established experimentally many years ago by Blalock² and by Parsons and Phemister.₁₃ However, efforts to assist in the maintenance of blood pressure by increasing the peripheral resistance have been increasingly common in recent years, particularly since the advent of pressor agents such as levarterenol and phenylephrine Neo-Synephrine. Objections have been raised to the production of normotensive pressures by this method, in the presence of hypovolemia, since the problem of maintaining blood flow through vital tissues is by no means assured.¹⁰ Thus Remington et al.¹⁴ reported that the use of levarterenol decreased the survival time of dogs subjected to hemorrhagic shock, while Langston and Guyton⁷ showed that levarterenol by its direct action on the kidney, decreased . . . [Full Text PDF of this Article]

Author Affiliations
Jerusalem, Israel

From the Department of Surgery and the Laboratory for Surgical Research, The Rothschild Hadassah University Hospital and The Hebrew University-Hadassah Medical School.

Footnotes
Submitted for publication Feb. 15, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?